218 related articles for article (PubMed ID: 22405584)
1. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour.
Masdea L; Kulik EM; Hauser-Gerspach I; Ramseier AM; Filippi A; Waltimo T
Arch Oral Biol; 2012 Aug; 57(8):1041-7. PubMed ID: 22405584
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
[TBL] [Abstract][Full Text] [Related]
3. The antimicrobial activity of alpha-bisabolol and tea tree oil against Solobacterium moorei, a Gram-positive bacterium associated with halitosis.
Forrer M; Kulik EM; Filippi A; Waltimo T
Arch Oral Biol; 2013 Jan; 58(1):10-6. PubMed ID: 22939370
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
Yoo HJ; Jwa SK; Kim DH; Ji YJ
Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
[TBL] [Abstract][Full Text] [Related]
5. The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics.
Burton JP; Chilcott CN; Tagg JR
Oral Dis; 2005; 11 Suppl 1():29-31. PubMed ID: 15752094
[TBL] [Abstract][Full Text] [Related]
6. Distribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction.
Horz HP; Meinelt A; Houben B; Conrads G
Oral Microbiol Immunol; 2007 Apr; 22(2):126-30. PubMed ID: 17311636
[TBL] [Abstract][Full Text] [Related]
7. Developing oral probiotics from Streptococcus salivarius.
Wescombe PA; Hale JD; Heng NC; Tagg JR
Future Microbiol; 2012 Dec; 7(12):1355-71. PubMed ID: 23231486
[TBL] [Abstract][Full Text] [Related]
8. Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
Tagg JR
Indian J Med Res; 2004 May; 119 Suppl():13-6. PubMed ID: 15232154
[TBL] [Abstract][Full Text] [Related]
9. Effect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model.
Ishijima SA; Hayama K; Burton JP; Reid G; Okada M; Matsushita Y; Abe S
Appl Environ Microbiol; 2012 Apr; 78(7):2190-9. PubMed ID: 22267663
[TBL] [Abstract][Full Text] [Related]
10. Effect of cinnamon (Cinnamomum verum) bark essential oil on the halitosis-associated bacterium Solobacterium moorei and in vitro cytotoxicity.
LeBel G; Haas B; Adam AA; Veilleux MP; Lagha AB; Grenier D
Arch Oral Biol; 2017 Nov; 83():97-104. PubMed ID: 28743086
[TBL] [Abstract][Full Text] [Related]
11. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
Park JA; Lee GR; Lee JY; Jin BH
Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
[TBL] [Abstract][Full Text] [Related]
12. Characterization and prevalence of Solobacterium moorei associated with oral halitosis.
Haraszthy VI; Gerber D; Clark B; Moses P; Parker C; Sreenivasan PK; Zambon JJ
J Breath Res; 2008 Mar; 2(1):017002. PubMed ID: 21386146
[TBL] [Abstract][Full Text] [Related]
13. Characterization of volatile sulfur compound production by Solobacterium moorei.
Tanabe S; Grenier D
Arch Oral Biol; 2012 Dec; 57(12):1639-43. PubMed ID: 23088790
[TBL] [Abstract][Full Text] [Related]
14. In vitro growth characteristics and volatile sulfur compound production of Solobacterium moorei.
Stephen AS; Naughton DP; Pizzey RL; Bradshaw DJ; Burnett GR
Anaerobe; 2014 Apr; 26():53-7. PubMed ID: 24487184
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial effect of probiotic bacteriocins on
Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
[TBL] [Abstract][Full Text] [Related]
16. Extended Safety Data for the Oral Cavity Probiotic Streptococcus salivarius K12.
Burton JP; Chilcott CN; Wescombe PA; Tagg JR
Probiotics Antimicrob Proteins; 2010 Oct; 2(3):135-44. PubMed ID: 26781236
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Streptococcus salivarius K12 on Halitosis: a Double-Blind, Randomized, Placebo-Controlled Trial.
He L; Yang H; Chen Z; Ouyang X
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1321-1329. PubMed ID: 32227309
[TBL] [Abstract][Full Text] [Related]
18. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
[TBL] [Abstract][Full Text] [Related]
19. The streptococcal inhibitor of complement (SIC) protects Streptococcus pyogenes from bacteriocin-like inhibitory substance (BLIS) from Streptococcus salivarius.
Minami M; Ohmori D; Tatsuno I; Isaka M; Kawamura Y; Ohta M; Hasegawa T
FEMS Microbiol Lett; 2009 Sep; 298(1):67-73. PubMed ID: 19594623
[TBL] [Abstract][Full Text] [Related]
20. Megaplasmids encode differing combinations of lantibiotics in Streptococcus salivarius.
Wescombe PA; Burton JP; Cadieux PA; Klesse NA; Hyink O; Heng NC; Chilcott CN; Reid G; Tagg JR
Antonie Van Leeuwenhoek; 2006 Oct; 90(3):269-80. PubMed ID: 16871420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
